Neurocrine Biosciences Inc. (1NBIX)
MTA
Real-time Data
07:00 AM
Day's Range
133.2052 wk Range
101.00Overview - 1NBIX - Neurocrine Biosciences Inc.
Key Statistics
Valuation
Enterprise Value
11.52B
P/E (Trailing)
‪22.55‬
PEG Ratio
‪0.72‬
Price / Sales (TTM)
‪3.97‬
Price / Book
‪4.20‬
EV / EBITDA
‪14.76‬
Profitability
Gross Margin
‪97.58%‬
Profit Margin
‪20.91%‬
Operating Margin
‪22.19%‬
Return on Assets
‪11.70%‬
Return on Equity
‪22.08%‬
Ownership
Shares Outstanding
101.60M
Float
100.38M
Held by Insiders
‪1.06%‬
Held by Institutions
‪102.80%‬
Price stats
Beta
‪0.39‬
50-Day Avg
‪150.03‬
200-Day Avg
‪127.87‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1NBIX - Neurocrine Biosciences Inc.
Peers - 1NBIX - Neurocrine Biosciences Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on MTA.
- 1NBIXMTANeurocrine Biosciences Inc.12.55BMarket Cap+19.30%52-week change22.23P/E (Trailing)‪20.91%‬Profit Margin
- 1MRKMTAMerck KGaA55.65BMarket Cap+20.17%52-week change23.47P/E (Trailing)‪11.21%‬Profit Margin
- 1ZTSMTAZoetis Inc.48.46BMarket Cap-106.01%52-week change12.02P/E (Trailing)‪27.68%‬Profit Margin
- 1GALDMTAGalderma Group AG41.32BMarket Cap+22.58%52-week change56.73P/E (Trailing)‪14.57%‬Profit Margin
- 1VTRSMTAViatris Inc.12.51BMarket Cap+36.15%52-week change-4.70P/E (Trailing)‪-2.78%‬Profit Margin
- 1SOBIMTASwedish Orphan Biovitrum AB10.24BMarket Cap+38.32%52-week change118.86P/E (Trailing)‪4.51%‬Profit Margin
- 1LNTHMTALantheus Holdings, Inc.3.88BMarket Cap+46.67%52-week change24.44P/E (Trailing)‪17.69%‬Profit Margin
Profile Summary - 1NBIX - Neurocrine Biosciences Inc.
About
Neurocrine Biosciences Inc. is a neuroscience-focused biopharmaceutical company specializing in the discovery, development, and commercialization of treatments for neurological, neuropsychiatric, endocrine, and metabolic disorders. Its flagship product, INGREZZA (valbenazine), a VMAT2 inhibitor, addresses tardive…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
